Not Signed In - [ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
Diabetic Eye Disease |
Diabetic Eye Problems; Diabetic retinopathy |
Clinical Trial: Bi-Axial Rotating Magnetic Field Therapy in Refractory Neuropathic Foot Pain Secondary to Diabetic Peripheral Neuropathy
This study is not yet open for patient recruitment.
|
Purpose
Application of commercial pulsed magnetic stimulating device to feet of patients with moderate-severe foot pain secondary to DPN
| Condition | Intervention | Phase |
|---|---|---|
| diabetic peripheral neuropathic pain sleep benefit diabetic peripheral neuropathic functioning | Device: foot energizer | Phase IV |
MedlinePlus consumer health information
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Official Title: Bi-Axial Rotating Magnetic Field Therapy in Refractory Neuropathic Foot Pain Secondary to Diabetic Peripheral Neuropathy. Multi-Center, Randomized Placebo Controlled Trial
Further Study Details:
Primary Outcomes: reduction of neuropathic foot pain, improve quality of life
Secondary Outcomes: serial changes in edx, QST, autonomic functions, biopsy
Expected Total Enrollment: 250
Secondary Outcomes: serial changes in edx, QST, autonomic functions, biopsy
Expected Total Enrollment: 250
Study start: August 2005; Expected completion: December 2006
Last follow-up: December 2006; Data entry closure: December 2006
see protocol
Eligibility
Ages Eligible for Study: 18 Years - 90 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- DPN stage 2 & 3, symptomatic > 6months
Exclusion Criteria:
- Pacemaker in patient or mate
Location and Contact Information
Please refer to this study by ClinicalTrials.gov identifier NCT00123136
Michael I. Weintraub, MD 914-941-0788 miwneuro@pol.net
New York
Michael I. Weintraub MD 325 S. Highland Aveneue, Briarcliff, New York, 10510, United States
susan wolert, data, Sub-Investigator
Study chairs or principal investigators
Michael Weintrab, MD, Principal Investigator, New York Medical College
More Information
Study ID Numbers: 2005-81440-DPN; NA
Record last reviewed: July 2005
Last Updated: July 25, 2005
Record first received: July 21, 2005
ClinicalTrials.gov Identifier: NCT00123136
Health Authority: United States: Institutional Review Board
ClinicalTrials.gov processed this record on 2005-07-26
Record last reviewed: July 2005
Last Updated: July 25, 2005
Record first received: July 21, 2005
ClinicalTrials.gov Identifier: NCT00123136
Health Authority: United States: Institutional Review Board
ClinicalTrials.gov processed this record on 2005-07-26
Resources
- ¿Cuánto Sabe Sobre la Enfermedad Diabética del Ojo? (National Eye Institute, NIH, HHS)
- Diabetes: Think of all the beautiful things you wouldn’t see if you lost your sight (National Eye Institute)
email this page
print this page
bookmark this page
feedback on this page
